DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS
剖析 MTBP 在骨肉瘤转移中的作用
基本信息
- 批准号:7610681
- 负责人:
- 金额:$ 33.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAttenuatedBAX geneBax proteinBindingBinding ProteinsCDKN1A geneCell CycleComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentFundingG1 ArrestGenetic TranscriptionGoalsGrantInstitutionKnock-outKnockout MiceMalignant NeoplasmsMetastatic OsteosarcomaMusMutateNeoplasm MetastasisNumbersOsteoblastsPathway interactionsPatientsPlayProteinsProtocols documentationResearchResearch PersonnelResourcesRoleSourceStressTP53 geneTherapeuticTumor Suppressor ProteinsUnited States National Institutes of HealthWorkbasedesignin vivoinhibitor/antagonistmutantnoveloncoprotein p21osteosarcomaoutcome forecasttumoryeast two hybrid system
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Our long-term goal is to elucidate the impact of the Mdm2-p53 pathway in vivo on tumor development as a necessary prerequisite to the development of therapeutic protocols for attenuating cancer. p53 functions as a tumor suppressor and exerts this function by activating numerous downstream targets such as p21, BAX, PUMA, GADD45 as a transcription factor1. Mdm2 is a major inhibitor of p53 through physical binding and induction of p53 degradation2. The p53 gene is mutated in more than 50% of tumors, and Mdm2 is highly expressed in a variety of tumors, stressing the importance of the Mdm2-p53 pathway in tumor development 3-6. It should be noted that a significant number of tumors have wild-type p53 with Mdm2 over-expression. Interestingly, some patients with tumors in which p53 gene is mutated and Mdm2 is over-expressed are known to have a poorer prognosis, compared to patients with mutant p53 alone in tumors7, 8. These results suggest that Mdm2 also has p53-independent roles in tumor development. Recently, Mdm2 is found to inhibitory interact with other tumor suppressors such as Rb, PML, and p73, which may contribute to p53-independent roles of Mdm2 in tumor development9-15. One can assume that any proteins that affect Mdm2 function may have an impact on tumor development.
Mdm2 Binding Protein (MTBP) was isolated by Boyd MT et al.16 using the yeast two hybrid system with Mdm2 as bait. Over-expression of MTBP causes G1 arrest of cell cycle, but the effect is nullified by simultaneous over-expression of Mdm2. Our working hypothesis is that MTBP plays a critical role in tumor development and metastasis. This hypothesis is based on our preliminary results using a conventional mtbp knockout mouse in which we observed that (1) 30% of mtbp heterozygous mice spontaneously developed tumors within 22 months, and (2) doubly heterozygous knockout mice for mtbp and p53 developed metastatic osteosarcomas. Based on these observations, the focus of this proposal is on the roles of MTBP in osteosarcoma metastasis and the functional characterization of this protein. The specific aims are designed to provide a comprehensive assessment of novel functions of MTBP, especially in osteosarcoma metastasis.
Aim 1. To characterize osteosarcomas induced by loss of mtbp.
Aim 2. To generate and characterize mice with conditional mtbp and/or p53 knockout alleles, specifically in osteoblasts.
Aim 3. To isolate MTBP interacting proteins.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
我们的长期目标是阐明体内MDM2-P53通路对肿瘤发展的影响,作为开发减轻癌症治疗方案的必要前提。P53作为一种肿瘤抑制因子,通过激活p21、Bax、PUMA、GADD45等下游靶基因作为转录因子发挥作用。MDM2通过物理结合和诱导P53降解,是P53的主要抑制因子。P53基因在超过50%的肿瘤中发生突变,MDM2在各种肿瘤中高度表达,强调了MDM2-p53通路在肿瘤发生发展中的重要性3-6。应该注意的是,相当多的肿瘤具有野生型p53和MDM2的过度表达。有趣的是,一些p53基因突变和MDM2过度表达的肿瘤患者与肿瘤中仅有突变型p53的患者相比,预后更差。这些结果表明,MDM2在肿瘤的发展中也具有P53非依赖的作用。最近,MDM2被发现与其他肿瘤抑制因子如Rb、PML和p73相互作用,这可能有助于MDM2在肿瘤发展中不依赖于p53的作用9-15。人们可以假设,任何影响MDM2功能的蛋白质都可能对肿瘤的发展产生影响。
MDM2结合蛋白(MTBP)是由Boyd MT等人用以MDM2为诱饵的酵母双杂交系统分离得到的。MTBP过表达导致细胞周期G1期停滞,但其作用被MDM2过表达所抵消。我们的工作假设是MTBP在肿瘤的发展和转移中起着关键作用。这一假设是基于我们使用传统mtBP基因敲除小鼠的初步结果,在该小鼠中,我们观察到(1)30%的mtBP杂合小鼠在22个月内自发发生肿瘤,(2)mtBP和p53双重杂合敲除小鼠发展为转移性骨肉瘤。基于这些观察,这项建议的重点是MTBP在骨肉瘤转移中的作用以及该蛋白的功能特征。这些特定的目的是为了全面评估MTBP的新功能,特别是在骨肉瘤转移中。
目的1.研究线粒体结合蛋白缺失所致骨肉瘤的特征。
目的2.建立和鉴定具有条件mtBP和/或p53基因敲除等位基因的小鼠,尤其是成骨细胞。
目的3.分离MTBP相互作用蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tomoo Iwakuma其他文献
Tomoo Iwakuma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tomoo Iwakuma', 18)}}的其他基金
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis
通过甲羟戊酸途径-DNAJA1 轴控制突变体 p53 的稳定性
- 批准号:
10320158 - 财政年份:2021
- 资助金额:
$ 33.52万 - 项目类别:
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis
通过甲羟戊酸途径-DNAJA1 轴控制突变体 p53 的稳定性
- 批准号:
10339474 - 财政年份:2021
- 资助金额:
$ 33.52万 - 项目类别:
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis
通过甲羟戊酸途径-DNAJA1 轴控制突变体 p53 的稳定性
- 批准号:
9523990 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
The role of MDM2-MTBP axis in cancer metastasis
MDM2-MTBP轴在癌症转移中的作用
- 批准号:
8694358 - 财政年份:2014
- 资助金额:
$ 33.52万 - 项目类别:
The role of MDM2-MTBP axis in cancer metastasis
MDM2-MTBP轴在癌症转移中的作用
- 批准号:
8842602 - 财政年份:2014
- 资助金额:
$ 33.52万 - 项目类别:
DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS
剖析 MTBP 在骨肉瘤转移中的作用
- 批准号:
7720778 - 财政年份:2008
- 资助金额:
$ 33.52万 - 项目类别:
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBP
揭示 MTBP 抑制骨肉瘤转移的机制
- 批准号:
8168370 - 财政年份:2004
- 资助金额:
$ 33.52万 - 项目类别:
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBP
揭示 MTBP 抑制骨肉瘤转移的机制
- 批准号:
8360720 - 财政年份:2004
- 资助金额:
$ 33.52万 - 项目类别:
DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS
剖析 MTBP 在骨肉瘤转移中的作用
- 批准号:
7960535 - 财政年份:2004
- 资助金额:
$ 33.52万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 33.52万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 33.52万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 33.52万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 33.52万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 33.52万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 33.52万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 33.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 33.52万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 33.52万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 33.52万 - 项目类别: